Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2013 5
2015 2
2017 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Misdiagnosis in Fabry disease.
Marchesoni CL, Roa N, Pardal AM, Neumann P, Cáceres G, Martínez P, Kisinovsky I, Bianchi S, Tarabuso AL, Reisin RC. Marchesoni CL, et al. Among authors: kisinovsky i. J Pediatr. 2010 May;156(5):828-31. doi: 10.1016/j.jpeds.2010.02.012. J Pediatr. 2010. PMID: 20385321
Neuro-Otological and Peripheral Nerve Involvement in Fabry Disease.
Carmona S, Weinschelbaum R, Pardal A, Marchesoni C, Zuberbuhler P, Acosta P, Cáceres G, Kisinovsky I, Bayón L, Reisin R. Carmona S, et al. Among authors: kisinovsky i. Audiol Res. 2017 Jul 28;7(2):176. doi: 10.4081/audiores.2017.176. eCollection 2017 Jul 18. Audiol Res. 2017. PMID: 28794847 Free PMC article.
Major cardiovascular adverse events in Fabry disease patients receiving agalsidase alfa.
Ferrari G, Reisin R, Kisinovsky I, Neumann P, Dragonetti L, Cáceres G, Choua M, Rozenfeld P, Marchesoni C, Finn V; Asociación Argentina de Estudio y Tratamiento de Fabry y otras Enfermedades Lisosomales (AADELFA), Fabry disease investigators. Ferrari G, et al. Among authors: kisinovsky i. Medicina (B Aires). 2021;81(2):173-179. Medicina (B Aires). 2021. PMID: 33906135 Free article. English.
[Guidelines for diagnosis, monitoring and treatment of Fabry disease].
Consenso de Médicos de AADELFA y GADYTEF; Neumann P, Antongiovanni N, Fainboim A, Kisinovsky I, Amartino H, Cabrera G, Carmona S, Ceci R, Cicerán A, Choua M, Doxastakis G, De Maio S, Ebner R, Escobar AM, Ferrari G, Forrester M, Guelbert N, Luna P, Marchesoni C, Masllorens F, Politei J, Reisin R, Ripeau D, Rozenfeld P, Serebrinsky G, Tarabuso AL, Trípoli J. Consenso de Médicos de AADELFA y GADYTEF, et al. Among authors: kisinovsky i. Medicina (B Aires). 2013;73(5):482-94. Medicina (B Aires). 2013. PMID: 24152410 Free article. Spanish.
Brain MRI findings in patients with Fabry disease.
Reisin RC, Romero C, Marchesoni C, Nápoli G, Kisinovsky I, Cáceres G, Sevlever G. Reisin RC, et al. Among authors: kisinovsky i. J Neurol Sci. 2011 Jun 15;305(1-2):41-4. doi: 10.1016/j.jns.2011.03.020. Epub 2011 Apr 3. J Neurol Sci. 2011. PMID: 21463870
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.
Ben Turkia H, Gonzalez DE, Barton NW, Zimran A, Kabra M, Lukina EA, Giraldo P, Kisinovsky I, Bavdekar A, Ben Dridi MF, Gupta N, Kishnani PS, Sureshkumar EK, Wang N, Crombez E, Bhirangi K, Mehta A. Ben Turkia H, et al. Among authors: kisinovsky i. Am J Hematol. 2013 Mar;88(3):179-84. doi: 10.1002/ajh.23382. Epub 2013 Feb 9. Am J Hematol. 2013. PMID: 23400823 Free article. Clinical Trial.
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study.
Gonzalez DE, Turkia HB, Lukina EA, Kisinovsky I, Dridi MF, Elstein D, Zahrieh D, Crombez E, Bhirangi K, Barton NW, Zimran A. Gonzalez DE, et al. Among authors: kisinovsky i. Am J Hematol. 2013 Mar;88(3):166-71. doi: 10.1002/ajh.23381. Epub 2013 Feb 6. Am J Hematol. 2013. PMID: 23386328 Free article. Clinical Trial.
12 results